Editas Medicine (EDIT) Reports In-Line Q3 EPS
Editas Medicine (NASDAQ: EDIT) reported Q3 EPS of ($0.75), in-line with the analyst estimate of ($0.75).
For earnings history and earnings-related data on Editas Medicine (EDIT) click here.
Editas Medicine (NASDAQ: EDIT) reported Q3 EPS of ($0.75), in-line with the analyst estimate of ($0.75).
For earnings history and earnings-related data on Editas Medicine (EDIT) click here.